Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 715M | 6.4B | 5.5B | 5.4B |
Cost of revenue | 42M | 337M | 273M | 190M |
Gross profit | 673M | 6.1B | 5.3B | 5.2B |
Operating expense | ||||
Research & development | 359M | 2.7B | 2.3B | 2.5B |
Selling general and admin | 126M | 1.2B | 865M | 894M |
Other operating expenses | — | — | — | — |
Operating income | 188M | 2.2B | 2.1B | 1.8B |
Non operating interest income | ||||
Income | 33M | 224M | 162M | 292M |
Expense | 5M | 54M | 18M | 19M |
Other income expense | 28M | 1.2B | -544M | 38M |
Pretax income | 244M | 3.6B | 1.7B | 2.1B |
Tax provision | 49M | -243M | 453M | 719M |
Net income | 195M | 3.8B | 1.3B | 1.4B |
Basic EPS | 3.1 | — | 19.9 | 21.9 |
Diluted EPS | 3.1 | — | 19.8 | 21.7 |
Basic average shares | 419.2M | — | 417.6M | 423.9M |
Diluted average shares | 420.6M | — | 420.4M | 426.8M |
EBITDA | 237M | 2.5B | 2.4B | 2.3B |
Net income from continuing op. | 244M | 3.6B | 1.7B | 3.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |